Skip to main content
NIH funding notice PA-10-213

Development of Assays for High-Throughput screening for use in Probe and Pre-therapeutic Discovery (R01)

Closed on September 7, 2013.

Posted
June 10, 2010
Close date
September 7, 2013
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,433,182 in first-year total cost, median $354,503.

Most frequent study sections

  1. Drug Discovery and Molecular Pharmacology Study Section[DMP]2
  2. Special Emphasis Panel[ZRG1 IDM-U (02)]2
  3. Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section[DDR]1
  4. Psychosocial Risk and Disease Prevention Study Section[PRDP]1

Most frequent institutions

  1. HARVARD MEDICAL SCHOOL1
  2. JOHNS HOPKINS UNIVERSITY1
  3. NATIONAL JEWISH HEALTH1
  4. SAINT LOUIS UNIVERSITY1
  5. UNIV OF NORTH CAROLINA CHAPEL HILL1
Competing awards under PA-10-213 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2014Tailored Treatment to Enhance Risk Perception in Sleep Apnea1R01HL120693-01ALOIA, MARK S.NATIONAL JEWISH HEALTH, CO$685,153PRDP
2014Chemical Tools for the Study of Dengue Virus Entry1R01AI095499-01A1GRAY, NATHANAEL SCHIANDERYANG, PRISCILLA LI-NINGHARVARD MEDICAL SCHOOL, MA$421,606ZRG1
2014Innate immunity-based screen for bacterial type III secretion system inhibitors1R01AI106930-01A1STONE, VICTORIA AUERBUCHUNIVERSITY OF CALIFORNIA SANTA CRUZ, CA$372,856DDR
2014Dual High-Throughput Imaging Screen for Nucleolar Integrity and RNA Transcription1R01CA172069-01A1LAIHO, MARIKKIJOHNS HOPKINS UNIVERSITY, MD$336,150DMP
2014A screen for antiviral compounds targeting the Hepatitis B Virus ribonuclease H1R01AI104494-01A1TAVIS, JOHN ESAINT LOUIS UNIVERSITY, MO$331,025ZRG1
2014Targeting the TLS DNA Damage Tolerance Pathway for Cancer Therapy1R01GM105883-01A1JANZEN, WILLIAM PERRYVAZIRI, CYRUSUNIV OF NORTH CAROLINA CHAPEL HILL, NC$286,392DMP

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.